Evidence map›Paper›PMID 30455960›Full record

ArticlePharmacology research & perspectives2018

Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding region.

Naofumi Seira, Kazuyuki Yamagata, Keijo Fukushima, Yumi Araki, Naoki Kurata, Naoki Yanagisawa, Masato Mashimo, Hiroyuki Nakamura, John W Regan, Toshihiko Murayama and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmacology research & perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Butyrate, IL-4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  2. Spatial mapping of the AA-PGEActa neuropathologica · 2025
    Article
  3. Review
  4. Article
  5. Molecular Crosstalk Between MYC and HIF in Cancer.Frontiers in cell and developmental biology · 2020
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Naofumi SeiraLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
Kazuyuki YamagataLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
Keijo FukushimaDepartment of Pharmacology for Life Sciences Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences Tokushima University Tokushima Japan.
Yumi ArakiLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
Naoki KurataLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
Naoki YanagisawaLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
Masato MashimoLaboratory of Pharmacology Faculty of Pharmaceutical Sciences Doshisha Women's College of Liberal Arts Kyotanabe, Kyoto Japan.
Hiroyuki NakamuraLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
John W ReganDepartment of Pharmacology & Toxicology College of Pharmacy The University of Arizona Tucson Arizona.
Toshihiko MurayamaLaboratory of Chemical Pharmacology Graduate School of Pharmaceutical Sciences Chiba University Chuo-ku Chiba Japan.
Hiromichi FujinoDepartment of Pharmacology for Life Sciences Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences Tokushima University Tokushima Japan.ORCID 0000-0002-5899-2095
Chiba University · JPTokushima University · JPDoshisha Women's College of Liberal Arts · JPUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The up-regulated expression of E-type prostanoid (EP) 4 receptors has been implicated in carcinogenesis; however, the expression of EP4 receptors has also been reported to be weaker in tumor tissues than in normal tissues. Indeed, EP4 receptors have been suggested to play a role in the maintenance of colorectal homeostasis. This study aimed to examine the underlying mechanisms/reasons for why inconsistent findings have been reported regarding EP4 receptor expression levels in homeostasis and carcinogenesis by focusing on cellular densities. Thus, the human colon cancer HCA-7 cells, which retain some functional features of normal epithelia, and luciferase reporter genes containing wild-type or mutated EP4 receptor promoters were used for elucidating the cellular density-dependent mechanisms about the regulation of EP4 receptor expression. In silico analysis was also utilized for confirming the relevance of the findings with respect to colon cancer development. We here demonstrated that the expression of EP4 receptors was up-regulated by c-Myc by binding to Sp-1 under low cellular density conditions, but was down-regulated under high cellular density conditions via the increase in the expression levels of HIF-1α protein, which may pull out c-Myc and Sp-1 from DNA-binding. The tightly regulated EP4 receptor expression mechanism may be a critical system for maintaining homeostasis in normal colorectal epithelial cells. Therefore, once the system is altered, possibly due to the transient overexpression of EP4 receptors, it may result in aberrant cellular proliferation and transformation to cancerous phenotypes. However, at the point, EP4 receptors themselves and their mediated homeostasis would be no longer required.

Indexed as

CarcinogenesisCell CountCell Line, TumorColonic NeoplasmsComputational BiologyDown-RegulationGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitPromoter Regions, GeneticProto-Oncogene Proteins c-mycReceptors, Prostaglandin E, EP4 SubtypeSp1 Transcription FactorUp-RegulationHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitMYC protein, humanProto-Oncogene Proteins c-mycPTGER4 protein, humanReceptors, Prostaglandin E, EP4 SubtypeSP1 protein, humanSp1 Transcription Factorc‐Myccolorectal cancerEP4 receptorsHIF‐1αhomeostasisSp‐1

Identifiers

PMID30455960
PMCPMC6230926
OpenAlexW2900904096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.